OTC Markets EXMKT - Delayed Quote USD

Eagle Pharmaceuticals, Inc. (EGRX)

Compare
0.7000
+0.1750
+(33.33%)
At close: January 10 at 3:57:50 PM EST
All numbers in thousands
Breakdown
12/31/2022
12/31/2021
12/31/2020
Total Assets
406,160.0000
253,732.0000
253,190.0000
Total Liabilities Net Minority Interest
172,600.0000
77,279.0000
67,179.0000
Total Equity Gross Minority Interest
233,560.0000
176,453.0000
186,011.0000
Total Capitalization
289,776.0000
176,453.0000
211,146.0000
Common Stock Equity
233,560.0000
176,453.0000
186,011.0000
Capital Lease Obligations
1,534.0000
1,309.0000
1,123.0000
Net Tangible Assets
70,200.0000
126,039.0000
133,351.0000
Working Capital
77,667.0000
98,230.0000
127,980.0000
Invested Capital
296,026.0000
202,060.0000
219,146.0000
Tangible Book Value
70,200.0000
126,039.0000
133,351.0000
Total Debt
64,000.0000
26,916.0000
34,258.0000
Net Debt
7,145.0000
--
--
Share Issued
17,569.3750
16,903.0340
16,739.2030
Ordinary Shares Number
13,016.6450
12,791.4120
13,057.0270
Treasury Shares Number
4,552.7300
4,111.6220
3,682.1760
12/31/2020 - 2/12/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers